Key result
Combined CA125, Galectin-3, and troponin panel evaluated as potential biomarker signature in AMI.
Why the study?
This study aimed to quantify circulating levels of Carbohydrate Antigen 125 (CA125), Galectin 3 (Gal-3), and the troponin complex to establish their utility as a combined panel for the assessment and prognosis of acute myocardial infarction.
Does the quantitative estimation of serum CA125, Galectin 3, and the Troponin complex serve as an effective combined biomarker panel for the assessment and prognosis of acute myocardial infarction compared to healthy controls?
Case-Control (n=90)
Yes
Does the quantitative estimation of serum CA125, Galectin 3, and the Troponin complex serve as an effective combined biomarker panel for the assessment and prognosis of acute myocardial infarction compared to healthy controls?
Answers are grounded in this paper and cite their sources.
Serum CA125 and Gal-3 levels in AMI remain hypothesis-generating; larger prospective studies needed before any clinical role.
This research investigates the serum concentrations of three distinct biomacromolecules—Carbohydrate Antigen 125 (CA125), Galectin 3 (Gal‐3), and the Troponin complex—in patients diagnosed with acute myocardial infarction (AMI). These molecules, characterized by their unique macromolecular structures (a high molecular weight glycoprotein, a beta‐galactoside‐binding lectin, and a heterotrimeric protein complex, respectively), serve as critical indicators of cardiac stress and tissue damage. The study was conducted at Tikrit Teaching Hospital and affiliated private laboratories, with patient diagnoses confirmed by specialist physicians based on clinical symptoms and pathological analyses. A total of 90 serum samples were collected between November 2024 and January 2025, comprising 60 samples from AMI patients and 30 from healthy control subjects, with ages ranging from 20 to 85 years in both groups. The primary objective was the quantitative estimation of the circulating levels of these three macromolecular biomarkers. The analysis of these biopolymeric entities aims to establish their utility as a combined panel for the assessment and prognosis of AMI. The findings of this study will contribute to a deeper understanding of the macromolecular changes that occur in the circulatory system following acute cardiac events, providing a foundation for future research into the structural and functional roles of these proteins in cardiovascular pathology.
No takes yet. Share an insight, caveat, or question.
Mutlaq et al. (2026) conducted a case-control in Acute myocardial infarction (AMI) (n=90). Serum CA125, Galectin 3, and Troponin complex vs. Healthy control subjects was evaluated on Circulating serum concentrations of CA125, Galectin 3, and Troponin complex.
Synapse has enriched 10 related papers. Consider them for comparative context: